The TGA has approved Bristol-Myers Squibb's OPDIVO (nivolumab) for three indications. …
Latest Video
New Stories
-
New preventive treatments could support ongoing fight against COVID
January 23, 2025 - - Latest News -
Pharmac encourages input on on multiple medicines funding proposal
January 22, 2025 - - Latest News -
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
January 22, 2025 - - Australian Biotech -
Emyria announces key leadership changes
January 22, 2025 - - Latest News -
Island Pharmaceuticals says all subjects now enrolled in key arm PROTECT clinical trial
January 22, 2025 - - Australian Biotech -
LTR Pharma signs national pharmacy distribution agreement with Symbion
January 22, 2025 - - BioPharma -
Make the case against the state's imposition of economic interests as the only consideration
January 21, 2025 - - Latest News